New approach to organizing primary health care for Alzheimer's management

Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease EvaMMADom

Not applicable Interventional Assistance Publique Hopitaux De Marseille · NCT03360552

This study tests a new way to manage Alzheimer's care for people with mild to moderate dementia to see if it improves their thinking skills, quality of life, and helps their caregivers compared to regular care.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment320 (estimated)
Ages65 Years and up
SexAll
SponsorAssistance Publique Hopitaux De Marseille Academic / other
Locations1 site (Marseille)
Trial IDNCT03360552 on ClinicalTrials.gov

What this trial studies

This study evaluates a new management strategy for Alzheimer's disease that involves a multidimensional evaluation of patients with mild to moderately severe dementia. It compares this approach to the usual care currently provided in primary health settings. The effectiveness of the new strategy will be assessed based on various factors, including cognitive functions, quality of life, and caregiver burden, over a follow-up period of 20 months. Additionally, a cost-effectiveness analysis will be conducted to determine the economic viability of this new approach.

Who should consider this trial

Good fit: Ideal candidates are patients over 64 years old with probable Alzheimer's disease and mild to moderately severe dementia.

Not a fit: Patients under 65 years old or those with severe dementia or early cognitive decline may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved management of Alzheimer's disease, enhancing patient outcomes and caregiver support.

How similar studies have performed: While similar approaches have been explored, this specific strategy is novel in its focus on multidimensional evaluations in primary care settings.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with probable Alzheimer's disease, according to the criteria usually used in memory centers
* Aged over 64 years with mild to moderately severe dementia syndrome
* Volunteers for medical follow-up for a period of 20 months; Which the general practitioner attending agrees to participate in the research

Exclusion Criteria:

* Patients under 65 years old
* presenting with early cognitive decline or severe dementia
* Not meeting the clinical diagnostic criteria for Alzheimer's disease
* Refusing or unable to sign informed consent to participate
* Not voluntary for medical follow-up for a period of 20 months
* Whose general practitioner refuses to participate in the research

Where this trial is running

Marseille

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Alzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.